According to recent studies regarding head and neck squamous cell carcinoma, HSPB5 is regulated by the ROS formation, which could be related to increased survival of cells and one of the possible mechanisms of unresponsiveness to the applied therapy (van de Schootbrugge et al., 2014[60]). This evidence concerns the gene CRYAB and head and neck squamous cell carcinoma.